Citation: | Ruoyang Zhang, Lina Cai, Zeeshan Ali, Jiuhai Wang, Enyong Fan, Mingyuan Wang, Minhui Wu, Zhiyang Li, Wenbiao Liang. A chemiluminescence based approach to nucleic acid testing to detect HBV, HCV, and HIV-1 in blood screening[J]. Blood&Genomics, 2023, 7(1): 34-42. doi: 10.46701/BG.2023012022032 |
[1] |
Roth WK, Busch MP, Schuller A, et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009[J]. Vox Sang, 2012, 102(1): 82−90. doi: 10.1111/j.1423-0410.2011.01506.x
|
[2] |
Sauvage V, Laperche S, Cheval J, et al. Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections[J]. Blood Transfus, 2016, 14(5): 400−407. doi: 10.2450/2016.0160-15
|
[3] |
Op de Coul ELM, Hogema BM, Sane J, et al. Evaluation of a fourth-generation avidity assay for recent HIV infections among men who have sex with men in Amsterdam[J]. J Med Microbiol, 2014, 63(8): 1116−1117. doi: 10.1099/jmm.0.074518-0
|
[4] |
Kwon JR, Won EJ, Jo HJ, et al. Serious adverse transfusion reactions reported in the national recipient-triggered trace back system in Korea (2006–2014)[J]. Ann Lab Med, 2016, 36(4): 335−341. doi: 10.3343/alm.2016.36.4.335
|
[5] |
Kiely P, Catton M, Brown D, et al. The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors[J]. Blood Transfus, 2015, 13(4): 669−671. doi: 10.2450/2015.0034-15
|
[6] |
Saber HR, Tabatabaee SM, Abasian A, et al. Incidence and residual risk of HIV, HBV and HCV infections among blood donors in Tehran[J]. Indian J Hematol Blood Transfus, 2017, 33(3): 412−416. doi: 10.1007/s12288-016-0732-5
|
[7] |
Kumar R, Gupta S, Kaur A, et al. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety[J]. Asian J Transfus Sci, 2015, 9(2): 199−202. doi: 10.4103/0973-6247.154250
|
[8] |
Rejali NA, Zuiter AM, Quackenbush JF, et al. Reverse transcriptase kinetics for one-step RT-PCR[J]. Anal Biochem, 2020, 601: 113768. doi: 10.1016/j.ab.2020.113768
|
[9] |
Ali Z, Wang J, Tang Y, et al. Simultaneous detection of multiple viruses based on chemiluminescence and magnetic separation[J]. Biomater Sci, 2017, 5(1): 57−66. doi: 10.1039/c6bm00527f
|
[10] |
Lelie N, Bruhn R, Busch M, et al. Detection of different categories of hepatitis B virus (HBV) infection in a multi-regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV-DNA testing[J]. Transfusion, 2017, 57(1): 24−35. doi: 10.1111/trf.13819
|
[11] |
Laperche S, Nübling CM, Stramer SL, et al. Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples[J]. Transfusion, 2015, 55(10): 2489−2498. doi: 10.1111/trf.13179
|
[12] |
Chacón L, Mateos ML, Holguín Á. Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting[J]. J Clin Virol, 2017, 92: 11−13. doi: 10.1016/j.jcv.2017.04.014
|
[13] |
Hasanzadeh M, Shadjou N, de la Guardia M. Iron and iron-oxide magnetic nanoparticles as signal-amplification elements in electrochemical biosensing[J]. TrAC-Trend Anal Chem, 2015, 72: 1−9. doi: 10.1016/j.trac.2015.03.016
|
[14] |
Wang J, Ali Z, Si J, et al. Simultaneous extraction of DNA and RNA from hepatocellular carcinoma (Hep G2) based on silica-coated magnetic nanoparticles[J]. J Nanosci Nanotechnol, 2017, 17(1): 802−806. doi: 10.1166/jnn.2017.12442
|
[15] |
Li Z, Wang J, Yang H, et al. Ultrasensitive detection of gastric cancer plasma microRNAs via magnetic beads-based chemiluminescent assay[J]. J Biomed Nanotechnol, 2017, 13(10): 1272−1280. doi: 10.1166/jbn.2017.2426
|
[16] |
Zhu W, Zeng J, Li T, et al. Evaluation of the application of Chemiluminescence immunoassay(CLIA) in blood screening[J]. Chin J Blood Transfus (in Chinese), 2016, 29(6): 581−583. doi: 10.13303/j.cjbt.issn.1004-549x.2016.06.008
|
[17] |
Li L, Xing W. The application of chemiluminescence in the detection of HCV/HIV[J]. Chin J AIDS STD (in Chinese), 2011, 17(3): 382−385. doi: 10.13419/j.cnki.aids.2011.03.034
|
[18] |
Zhang YF, Quan X, Song GC, et al. Clinical effects of CD200 on the outcome of acute myeloid leukemia patients with diverse treatments[J]. Blood Genom, 2022, 6(2): 133−140. doi: 10.46701/BG.2021022022018
|